• Profile
Close

Diagnostic and prognostic roles of circ-SHPRH for solid cancers: A meta-analysis

OncoTargets and Therapy Jun 06, 2019

Li F, et al. - Via this meta-analysis of nine eligible studies, researchers focused on if circ-SHPRH (a novel circular RNA which was down-regulated in various cancer tissues) had a diagnostic and/or prognostic role in solid cancers. They identified studies from PubMed, MEDLINE, Web of Science, Embase, China National Knowledge Infrastructure, and Wanfang database. They found pooled sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, diagnostic odds ratio, and area under the summary receiver operating characteristic curve were 0.79, 0.75, 3.20, 0.28, 11.27, and 0.84, respectively. A significant link of low circ-SHPRH expression with poor overall survival was indicated by pooled hazard ratio. circ-SHPRH was suggested to possibly be a significant diagnostic and prognostic biomarker for various solid cancers.

Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay